Bridgeman VL; Vermeulen PB; Foo S; Bilecz, Ágnes; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedűs, Balázs; Hoetzenecker K; Rényi-Vámos, Ferenc István; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku, Sándor; Kerbel RS; Döme, Balázs; Reynolds AR
(2017)
Anti-angiogenic therapies have shown limited efficacy in the clinical management of metastatic disease, including lung metastases. Moreover, the mechanisms via which tumours resist anti-angiogenic therapies are poorly ...